GLP-1 SG synthetic GLP-1 analog designed for advanced metabolic research and incretin pathway studies. Our GLP-1 SG provides scientists with high-purity glucagon-like peptide-1 receptor agonist featuring structural modifications that enhance stability and extend half-life for comprehensive laboratory investigations.
Product Specifications
- Molecular Weight: 4,113.6 Da
- Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
- Structure: Modified GLP-1 analog with C-18 fatty diacid chain attached to Lys²⁶
- Purity: 99% minimum via third-party testing
- Mechanism: High-affinity GLP-1 receptor agonist with extended duration
Research Applications
This synthetic GLP-1 analog enables comprehensive laboratory investigations including:
- GLP-1 receptor signaling pathway research examining adenylyl cyclase activation
- Incretin hormone mechanism studies investigating glucose-dependent insulin secretion
- Glucose homeostasis regulation models through glucagon suppression pathways
- Central appetite regulation research using metabolic signaling protocols
- Cellular pathway investigations examining cAMP-mediated signaling cascades
Molecular Mechanism
This research compound binds to and activates the GLP-1 receptor, stimulating adenylyl cyclase and increasing intracellular cAMP levels. This activation triggers multiple signaling pathways that influence glucose-dependent insulin secretion, glucagon suppression, and central appetite regulation, making it valuable for studying incretin biology and metabolic signaling dynamics.
Laboratory Protocols
- Store lyophilized powder at -20°C
- Reconstitution: Bacteriostatic water recommended for research applications
- Reconstituted solutions store at 2-8°C
- Avoid repeated freeze-thaw cycles
- Follow standard peptide handling protocols
Quality Assurance
Every batch undergoes rigorous third-party testing, ensuring molecular weight verification, purity confirmation, and bioactivity screening with complete Certificate of Analysis documentation.
For research purposes only. Not for human consumption or medical use.
